Combination therapy
US11351176B2 · kind B2 · utility
2Cited by
14References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 14, 2018 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Aug 14, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods of treating diseases, such as cancer, using a combination therapy. In certain embodiments, the methods comprise administering an effective amount of a phosphoinositide-3-kinase (PI3K) inhibitor and an effective amount of a CD20 inhibitor to a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.